Chief Financial Officer Alexander Dexne Leaves MediGene AG
Martinsried/Munich, May 8, 2007. The biotech company MediGene AG
(Frankfurt, Prime Standard: MDG) announced that Chief Financial
Officer Alexander Dexne will leave the company as from May 31, 2007.
Alexander Dexne has been Chief Financial Officer of MediGene AG since
May 2002. He has accepted a new position outside the biotech
industry.
Dr. Peter Heinrich, Chief Executive Officer of MediGene AG, comments:
"Alexander Dexne resigns from his position very much to the executive
and supervisory boards' regret. We would like to express our
gratitude for his valuable contribution to our company. The
supervisory board will soon appoint a qualified successor for the
position of the Chief Financial Officer."
This press release contains forward-looking statements that involve
risks and uncertainties. The forward-looking statements contained
herein represent the judgment of MediGene as of the date of this
release. These forward-looking statements are no guarantees for
future performance, and the forward-looking events discussed in this
press release may not occur. MediGene disclaims any intent or
obligation to update any of these forward-looking statements.
MediGeneTM and the MediGeneTM Logo are trademarks of MediGene AG.
- ends -
MediGene AG is a publicly quoted (Frankfurt: Prime Standard: MDG)
biotechnology company located in Martinsried/Munich, Germany, with
subsidiaries in Oxford, UK and San Diego, USA. MediGene is the first
German biotech company with a drug on the market. A second drug has
been approved by the FDA. A third drug was recently inlicensed to
market this drug in Europe. In addition, several drug candidates are
currently in clinical development. MediGene also possesses innovative
platform technologies.
Contact MediGene AG:
Email:
investor@medigene.com
Fax: ++49 - 89 - 85 65 - 2920
Julia Hofmann/Dr. Georg Dönges, Public Relations
Tel.: ++49 - 89 - 85 65 - 3317
Dr. Michael Nettersheim, Investor
Relations Tel.: ++49 - 89 - 85 65 -
2946
--- End of Message ---
MediGene AG
Lochhamer Strasse 11 Martinsried / München Germany
WKN:
502090; ISIN: DE0005020903 ; Index: Prime All Share, CDAX, TECH All
Share, HDAX, MIDCAP, TecDAX;
Listed: Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in
Bayerische Börse München,
Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr
in Niedersächsische Börse zu Hannover,
Geregelter Markt in Frankfurter Wertpapierbörse;